Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Phase III assessment of topotecan, cyclophosphamide and high-dose ifosfamide for...
Dr Martin McCabe- University of Manchester, Manchester, England
Phase III assessment of topotecan, cyclophosphamide and high-dose ifosfamide for refractory Ewing sarcoma patients ( Dr Martin McCabe- University of Manchester, Manchester, England )
5 Jun 2022
Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast can...
Shanu Modi- Memorial Sloan Ketting Cancer Center, Manhattan, USA
Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients ( Shanu Modi- Memorial Sloan Ketting Cancer Center, Manhattan, USA )
5 Jun 2022
(RVd) ± , stem cell transplantation and R maintenance shows significance for new...
Dr Paul Richardson- Dana Farber Cancer Institute, Boston, USA
(RVd) ± , stem cell transplantation and R maintenance shows significance for newly diagnosed myeloma patients ( Dr Paul Richardson- Dana Farber Cancer Institute, Boston, USA )
5 Jun 2022
Review: Best options in localised prostate cancer
Prof Eleni Efstathiou, Prof Oliver Sartor, Prof Kurt Miller and Prof Karim Fizaz...
Review: Best options in localised prostate cancer ( Prof Eleni Efstathiou, Prof Oliver Sartor, Prof Kurt Miller and Prof Karim Fizazi )
4 Jun 2022
Avasopasem produces significant improvement of severe oral mucositis in head and...
Dr Carryn Anderson - University of Texas Medical Branch, Texas, USA
Avasopasem produces significant improvement of severe oral mucositis in head and neck patients ( Dr Carryn Anderson - University of Texas Medical Branch, Texas, USA )
4 Jun 2022
Everolimus after surgery can improve outcomes in those with high-risk kidney can...
Dr Christopher Ryan - OHSU Knight Cancer Institute, Portland, USA
Everolimus after surgery can improve outcomes in those with high-risk kidney cancer ( Dr Christopher Ryan - OHSU Knight Cancer Institute, Portland, USA )
4 Jun 2022
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer
Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer ( Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA )
4 Jun 2022
The role of the Global Coalition for Radiotherapy in the war in Ukraine
Dr Ruslan Zelinskyi, Prof Patricia Price
The role of the Global Coalition for Radiotherapy in the war in Ukraine ( Dr Ruslan Zelinskyi, Prof Patricia Price )
25 May 2022
Inspiration Family: Challenges of the Ukrainian cancer charity on the frontline
Anna Uzlova - Inspiration Family, Kyiv, Ukraine
Inspiration Family: Challenges of the Ukrainian cancer charity on the frontline ( Anna Uzlova - Inspiration Family, Kyiv, Ukraine )
6 May 2022
War in Ukraine: The European Cancer Organisation's response to the refugee crisi...
Mike Morrissey - CEO, European Cancer Organisation
War in Ukraine: The European Cancer Organisation's response to the refugee crisis ( Mike Morrissey - CEO, European Cancer Organisation )
5 May 2022
War in Ukraine: The pyscho-oncology perspective
Prof Csaba Dégi - SEO, International Psycho-Oncology Society
War in Ukraine: The pyscho-oncology perspective ( Prof Csaba Dégi - SEO, International Psycho-Oncology Society )
5 May 2022
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients
Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients ( Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain )
28 Apr 2022